Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register

[1]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[2]  P. Sarma,et al.  Teratogenicity of antiepileptic dual therapy , 2018, Neurology.

[3]  A. Hitchcock,et al.  Antiepileptic drugs, foetal malformations and spontaneous abortions , 2017, Acta neurologica Scandinavica.

[4]  M. Eadie,et al.  Antiepileptic drug combinations not involving valproate and the risk of fetal malformations , 2016, Epilepsia.

[5]  M. Eadie,et al.  Is carbamazepine a human teratogen? , 2016, Journal of Clinical Neuroscience.

[6]  G. Koren,et al.  Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry , 2015, Therapeutic drug monitoring.

[7]  J. Graham,et al.  The teratogenicity of the newer antiepileptic drugs – an update , 2014, Acta neurologica Scandinavica.

[8]  M. Eadie,et al.  Prediction of the hazard of foetal malformation in pregnant women with epilepsy , 2014, Epilepsy Research.

[9]  M. Eadie,et al.  Associations between particular types of fetal malformation and antiepileptic drug exposure in utero , 2013, Acta neurologica Scandinavica.

[10]  T. O'Brien,et al.  Dose dependence of fetal malformations associated with valproate , 2013, Neurology.

[11]  B. Wlodarczyk,et al.  Antiepileptic drugs and pregnancy outcomes , 2012, American journal of medical genetics. Part A.

[12]  S. Hernández-Díaz,et al.  Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. , 2011, Archives of neurology.

[13]  T. Tomson,et al.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.

[14]  T. O'Brien,et al.  The teratogenic risk of antiepileptic drug polytherapy , 2010, Epilepsia.

[15]  S. B. Lucas,et al.  Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study , 2010, Seizure.

[16]  M. Martinez-frias,et al.  TOPIRAMATE IN PREGNANCY: PRELIMINARY EXPERIENCE FROM THE UK EPILEPSY AND PREGNANCY REGISTER , 2009, Neurology.

[17]  K. Meador,et al.  Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts , 2008, Epilepsy Research.

[18]  B. Irwin,et al.  Topiramate in pregnancy , 2006, Neurology.

[19]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  M. Eadie,et al.  Maternal valproate dosage and foetal malformations , 2005, Acta neurologica Scandinavica.

[21]  T. O'Brien,et al.  Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy , 2004, Journal of clinical neuroscience.

[22]  A. Ornoy,et al.  The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. , 2002, Reproductive toxicology.

[23]  M. Riley,et al.  Birth Defects in Victoria 1983–1998 , 2000 .

[24]  A. Hofman,et al.  Antiepileptic drug regimens and major congenital abnormalities in the offspring , 1999, Annals of neurology.

[25]  K. Inanaga,et al.  Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan , 1980, Epilepsia.